Improvement of Hailey–Hailey disease with abrocitinib

作者：Yufen Li, Yiqun Jiang, Jianfang Sun · 发表于：Clinical and Experimental Dermatology · 年份：2023 · DOI：10.1093/ced/llad023 · 被引用次数：24 · 研究领域：Genetic and rare skin diseases.、Hedgehog Signaling Pathway Studies、Cancer and Skin Lesions

We describe a patient with classical Hailey–Hailey disease who was successfully treated with the Janus kinase (JAK)1 inhibitor abrocitinib. To our knowledge, abrocitinib has not previously been described in the medical literature as a treatment option for HHD.